Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine：a phase I clinical trial

• Main Authors: Zhi-Wei Wu (Author), Qing-Liang Li (Author), Hai-Song Zhou (Author), Kai Duan (Author), Zhao Gao (Author), Xin-Jiang Zhang (Author), Zhi-Jun Jiang (Author), Zhi-Yong Hao (Author), Fei Jin (Author), Xuan Bai (Author), Qi Li (Author), Ge-Lin Xu (Author), Yu-Liang Zhao (Author), Xiao-Ming Yang (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Rotavirus infections, prevalent in human populations, are caused mostly by group A viruses. Immunization against rotaviruses in infancy is currently the most effective and economical strategy to prevent rotavirus infection. This study evaluated the safety of a novel hexavalent rotavirus v...